Education
About Us
Working with TipRanks
Follow Us
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
| May 24 | May 23 | May 22 | May 21 | May 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 50.64B | ¥ 46.90B | ¥ 45.10B | ¥ 43.46B | ¥ 45.00B |
| Gross Profit | ¥ 8.64B | ¥ 9.84B | ¥ 10.33B | ¥ 11.46B | ¥ 9.48B |
| Operating Income | ¥ 2.62B | ¥ 3.89B | ¥ 5.21B | ¥ 6.55B | ¥ 5.36B |
| EBITDA | ¥ 7.41B | ¥ 7.92B | ¥ 8.96B | ¥ 9.88B | ¥ 8.56B |
| Net Income | ¥ 1.91B | ¥ 3.29B | ¥ 3.60B | ¥ 4.67B | ¥ 3.94B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 2.21B | ¥ 2.73B | ¥ 3.61B | ¥ 4.38B | ¥ 3.08B |
| Total Assets | ¥ 78.00B | ¥ 77.71B | ¥ 70.55B | ¥ 64.94B | ¥ 54.25B |
| Total Debt | ¥ 11.88B | ¥ 8.72B | ¥ 4.96B | ¥ 3.45B | ¥ 3.37B |
| Net Debt | ¥ 9.68B | ¥ 5.99B | ¥ 1.35B | ¥ -934.00M | ¥ 280.90M |
| Total Liabilities | ¥ 25.93B | ¥ 25.44B | ¥ 19.58B | ¥ 17.27B | ¥ 17.38B |
| Stockholders' Equity | ¥ 52.00B | ¥ 52.07B | ¥ 50.67B | ¥ 47.30B | ¥ 36.51B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -957.00M | ¥ -1.09B | ¥ -1.40B | ¥ -363.00M | ¥ 1.53B |
| Operating Cash Flow | ¥ 5.90B | ¥ 5.18B | ¥ 4.16B | ¥ 4.37B | ¥ 4.31B |
| Investing Cash Flow | ¥ -7.37B | ¥ -5.93B | ¥ -5.57B | ¥ -4.40B | ¥ -2.68B |
| Financing Cash Flow | ¥ 1.00B | ¥ -183.00M | ¥ 616.00M | ¥ 989.00M | ¥ -350.46M |